Möchten Sie immer auf dem neuesten Stand bleiben?

Austin, TX, USA, July 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cardiac Tissue Engineering Market Size, Trends and Insights By Material...

New York City, NY, July 20, 2025 (GLOBE NEWSWIRE) -- In the world of strength training, the focus is shifting. With increasing scrutiny on banned substances and outdated bulking methods, more...

STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted conditional marketing...

STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted...

Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Vascular Access Devices - Company Evaluation Report, 2024" report has been added to ResearchAndMarkets.com's offering.The Vascular Access Devices...

Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Biopsy Devices - Company Evaluation Report, 2024" report has been added to ResearchAndMarkets.com's offering. The Biopsy Devices Companies Quadrant...

New York City, NY, July 18, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of muscle building, performance, and strength enhancement, CrazyBulk has emerged as the name reshaping the...

EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights...

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EURneffy® 2 mg in the United Kingdom (UK) for...

Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Tumor Ablation Market (By Technology, Treatment Mode, Application, End-User, Regional Analysis), Company Profiles, Product Portfolio, Recent...